New Delhi: Sun Pharma subsidiary has invested $13 million (about Rs. 88 crore) in the US-based scPharmaceuticals Inc.
“...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58 per cent fully diluted equity stake on conversion) by way of allotment,” Sun Pharmaceutical Industries said in a BSE filing today.
It further said: “Consideration for Series B preferred stock acquired is $13 million.”
scPharmaceuticals Inc is a United States-based pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Sun Pharma stock was trading 2.59 per cent higher at Rs. 625 on the BSE.
Disclaimer: You are responsible for your own investments. Niveza.in does not guarantee the accuracy or completeness of information on the site, nor does Niveza.in assume any liability for any loss that may result from reliance by any person upon any such information or recommendations. Such information recommendations are for general information only. Nothing contained herein is an offer to sell nor solicitation to buy any securities.